Publications Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours
Publications Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany
Publications Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer
Publications Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents
Publications Cost-effectiveness of denosumab versus zoledronic acid in the management of skeletal metastases secondary to breast cancer
Publications Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing-remitting multiple sclerosis in The Netherlands
Publications Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores
Publications Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C
Publications Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a cost-effectiveness analysis